Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology's Preferred Dividend Payments history spans 1 years, with the latest figure at $18.4 million for Q4 2023.

  • For Q4 2023, Preferred Dividend Payments changed N/A year-over-year to $18.4 million; the TTM value through Dec 2024 reached $18.4 million, down 41.15%, while the annual FY2023 figure was $18.8 million, N/A changed from the prior year.
  • Preferred Dividend Payments reached $18.4 million in Q4 2023 per CGON's latest filing, up from $5.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $18.4 million in Q4 2023 to a low of $3.7 million in Q1 2023.